Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
26.58
-0.08 (-0.30%)
Sep 29, 2026, 4:00 PM EDT - Market closed
Alto Neuroscience Employees
Alto Neuroscience had 68 employees as of December 31, 2025. The number of employees decreased by 8 or -10.53% compared to the previous year.
Employees
68
Change (1Y)
-8
Growth (1Y)
-10.53%
Revenue / Employee
n/a
Profits / Employee
-$1,238,794
Market Cap
1.04B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 68 | -8 | -10.53% |
| Dec 31, 2024 | 76 | 9 | 13.43% |
| Sep 30, 2024 | 88 | 27 | 44.26% |
| Jun 30, 2024 | 78 | 17 | 27.87% |
| Mar 31, 2024 | 67 | - | - |
| Sep 30, 2023 | 61 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MannKind | 592 |
| MeiraGTx Holdings | 393 |
| Monte Rosa Therapeutics | 173 |
| Janux Therapeutics | 113 |
| Adlai Nortye Group | 109 |
| Odyssey Therapeutics | 100 |
| Vor Biopharma | 76 |
| Seaport Therapeutics | 58 |
ANRO News
- 6 days ago - Alto Neuroscience Transcript: TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit - Transcripts
- 15 days ago - Alto Neuroscience Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 20 days ago - Alto Neuroscience Announces Participation in Upcoming Investor Conferences - Business Wire
- 4 weeks ago - Alto Neuroscience names Nick Smith president, CFO - TheFly
- 4 weeks ago - Alto Neuroscience Promotes Nick Smith to President and Chief Financial Officer - Business Wire
- 6 weeks ago - Alto Neuroscience price target raised to $55 from $50 at H.C. Wainwright - TheFly
- 6 weeks ago - Alto Neuroscience reports Q EPS (65c), consensus (77c) - TheFly
- 6 weeks ago - Alto Neuroscience price target raised to $37 from $28 at BTIG - TheFly